ZA96392B - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number: ZA96392B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1995-01-19

Application number

ZA96392A

Other languages

English (en)

Inventor

Simon Ruddick

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-19

Filing date

1996-01-18

Publication date

1996-08-29

1996-01-18 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1996-08-29 Publication of ZA96392B publication Critical patent/ZA96392B/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Extraction Or Liquid Replacement (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cephalosporin Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA96392A 1995-01-19 1996-01-18 Pharmaceutical formulations ZA96392B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9500977.5A GB9500977D0 (en)	1995-01-19	1995-01-19	Novel process

Publications (1)

Publication Number	Publication Date
ZA96392B true ZA96392B (en)	1996-08-29

Family

ID=10768206

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA96392A ZA96392B (en)	1995-01-19	1996-01-18	Pharmaceutical formulations

Country Status (30)

Country	Link
US (1)	US6172221B1 (de)
EP (1)	EP0804441B1 (de)
JP (1)	JP4111998B2 (de)
KR (1)	KR100446199B1 (de)
CN (1)	CN1105724C (de)
AP (1)	AP672A (de)
AT (1)	ATE261976T1 (de)
BG (1)	BG63308B1 (de)
BR (1)	BR9606919A (de)
CA (1)	CA2210748C (de)
CZ (1)	CZ294581B6 (de)
DE (1)	DE69631878T2 (de)
DK (1)	DK0804441T3 (de)
EA (1)	EA000277B1 (de)
ES (1)	ES2217302T3 (de)
FI (1)	FI113776B (de)
GB (1)	GB9500977D0 (de)
HU (1)	HU228768B1 (de)
MX (1)	MX9705498A (de)
NO (1)	NO317281B1 (de)
NZ (1)	NZ300604A (de)
OA (1)	OA10501A (de)
PL (1)	PL184468B1 (de)
PT (1)	PT804441E (de)
RO (1)	RO115956B1 (de)
SK (1)	SK284484B6 (de)
TR (1)	TR199700665T1 (de)
UA (1)	UA45380C2 (de)
WO (1)	WO1996022296A1 (de)
ZA (1)	ZA96392B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9500977D0 (en) *	1995-01-19	1995-03-08	Smithkline Beecham Plc	Novel process
AU2017295866A1 (en)	2016-07-14	2019-01-17	Achaogen, Inc.	Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
WO2020176806A1 (en) *	2019-02-27	2020-09-03	3-Delta, Inc.	Compositions that contain lipophilic plant material and surfactant, and related methods
US12264296B2 (en)	2020-09-02	2025-04-01	Michael V. Zumpano	Compositions that contain lipophilic plant material and surfactant, and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4110165A (en) *	1974-04-20	1978-08-29	Beecham Group Limited	Process for the production of clavulanic acid
DE3063683D1 (en)	1979-08-24	1983-07-14	Beecham Group Plc	Amine salt of clavulanic acid, its preparation and use
GB8404749D0 (en) *	1984-02-23	1984-03-28	Atomic Energy Authority Uk	Fluidic contactor
GB9401969D0 (en)	1994-02-02	1994-03-30	Smithkline Beecham Plc	Process
SI9400107A (en) *	1994-03-02	1995-10-31	Lek Tovarna Farmacevtskih	New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9500977D0 (en) *	1995-01-19	1995-03-08	Smithkline Beecham Plc	Novel process

1995
- 1995-01-19 GB GBGB9500977.5A patent/GB9500977D0/en active Pending
1996
- 1996-01-17 BR BR9606919A patent/BR9606919A/pt not_active Application Discontinuation
- 1996-01-17 PT PT96901326T patent/PT804441E/pt unknown
- 1996-01-17 HU HU9801699A patent/HU228768B1/hu unknown
- 1996-01-17 EA EA199700121A patent/EA000277B1/ru not_active IP Right Cessation
- 1996-01-17 EP EP96901326A patent/EP0804441B1/de not_active Expired - Lifetime
- 1996-01-17 JP JP52205796A patent/JP4111998B2/ja not_active Expired - Lifetime
- 1996-01-17 SK SK963-97A patent/SK284484B6/sk not_active IP Right Cessation
- 1996-01-17 WO PCT/EP1996/000270 patent/WO1996022296A1/en not_active Ceased
- 1996-01-17 AT AT96901326T patent/ATE261976T1/de active
- 1996-01-17 KR KR1019970704876A patent/KR100446199B1/ko not_active Expired - Lifetime
- 1996-01-17 MX MX9705498A patent/MX9705498A/es unknown
- 1996-01-17 ES ES96901326T patent/ES2217302T3/es not_active Expired - Lifetime
- 1996-01-17 AP APAP/P/1997/001022A patent/AP672A/en active
- 1996-01-17 DE DE69631878T patent/DE69631878T2/de not_active Expired - Lifetime
- 1996-01-17 UA UA97073840A patent/UA45380C2/uk unknown
- 1996-01-17 DK DK96901326T patent/DK0804441T3/da active
- 1996-01-17 RO RO97-01321A patent/RO115956B1/ro unknown
- 1996-01-17 NZ NZ300604A patent/NZ300604A/en not_active IP Right Cessation
- 1996-01-17 CA CA002210748A patent/CA2210748C/en not_active Expired - Lifetime
- 1996-01-17 CZ CZ19972252A patent/CZ294581B6/cs not_active IP Right Cessation
- 1996-01-17 US US08/875,240 patent/US6172221B1/en not_active Expired - Lifetime
- 1996-01-17 PL PL96321381A patent/PL184468B1/pl unknown
- 1996-01-17 CN CN96192663A patent/CN1105724C/zh not_active Expired - Lifetime
- 1996-01-17 TR TR97/00665T patent/TR199700665T1/xx unknown
- 1996-01-18 ZA ZA96392A patent/ZA96392B/xx unknown
1997
- 1997-07-07 BG BG101768A patent/BG63308B1/bg unknown
- 1997-07-18 FI FI973057A patent/FI113776B/fi not_active IP Right Cessation
- 1997-07-18 NO NO19973328A patent/NO317281B1/no not_active IP Right Cessation
- 1997-07-18 OA OA70054A patent/OA10501A/en unknown

Also Published As

Publication number	Publication date
FI113776B (fi)	2004-06-15
OA10501A (en)	2002-04-24
EA000277B1 (ru)	1999-02-25
CA2210748A1 (en)	1996-07-25
CA2210748C (en)	2008-04-01
EA199700121A1 (ru)	1997-12-30
CZ294581B6 (cs)	2005-02-16
EP0804441A1 (de)	1997-11-05
PT804441E (pt)	2004-07-30
HUP9801699A3 (en)	1999-03-01
FI973057L (fi)	1997-07-18
NZ300604A (en)	2000-06-23
CZ225297A3 (en)	1997-12-17
CN1179161A (zh)	1998-04-15
JPH10512557A (ja)	1998-12-02
DK0804441T3 (da)	2004-07-12
UA45380C2 (uk)	2002-04-15
SK284484B6 (sk)	2005-04-01
ES2217302T3 (es)	2004-11-01
HU228768B1 (en)	2013-05-28
DE69631878D1 (de)	2004-04-22
CN1105724C (zh)	2003-04-16
NO973328L (no)	1997-09-18
BG101768A (en)	1998-10-30
AU706196B2 (en)	1999-06-10
EP0804441B1 (de)	2004-03-17
DE69631878T2 (de)	2005-02-03
KR19980701485A (ko)	1998-05-15
BG63308B1 (bg)	2001-09-28
AP672A (en)	1998-09-09
HUP9801699A2 (hu)	1998-11-30
MX9705498A (es)	1997-10-31
RO115956B1 (ro)	2000-08-30
TR199700665T1 (xx)	1998-01-21
FI973057A0 (fi)	1997-07-18
SK96397A3 (en)	1998-02-04
PL321381A1 (en)	1997-12-08
PL184468B1 (pl)	2002-11-29
KR100446199B1 (ko)	2005-08-04
JP4111998B2 (ja)	2008-07-02
NO317281B1 (no)	2004-10-04
WO1996022296A1 (en)	1996-07-25
AP9701022A0 (en)	1997-07-31
NO973328D0 (no)	1997-07-18
US6172221B1 (en)	2001-01-09
ATE261976T1 (de)	2004-04-15
BR9606919A (pt)	1997-11-11
AU4539096A (en)	1996-08-07
GB9500977D0 (en)	1995-03-08
HK1004134A1 (en)	1998-11-20

Publication	Publication Date	Title
EG23826A (en)	2007-09-25	Pharmaceutical formulations
GB9523752D0 (en)	1996-01-24	Pharmaceutical formulations
AP9500733A0 (en)	1995-04-30	Pharmaceutical formulations
GB9519363D0 (en)	1995-11-22	Pharmaceutical formulation
ZA951781B (en)	1995-09-05	Pharmaceutical formulations
EP0862431A4 (de)	1999-07-07	Pharmazeutische formulierung
ZA967827B (en)	1997-03-18	Pharmaceutical compositions
EG24294A (en)	2009-01-08	Pharmaceutical compositions
GB9506382D0 (en)	1995-05-17	Pharmaceutical compositions
GB9513972D0 (en)	1995-09-06	Pharmaceutical compositions
GB9523566D0 (en)	1996-01-17	Pharmaceutical formulation
ZA96526B (en)	1996-08-06	Novel pharmaceutical formulation
AP9801196A0 (en)	1998-03-31	Pharmaceutical preparation
ZA96392B (en)	1996-08-29	Pharmaceutical formulations
GB9413542D0 (en)	1994-08-24	Pharmaceutical formulations
GB9500978D0 (en)	1995-03-08	Pharmaceutical formulations
ZA967542B (en)	1997-03-20	Pharmaceutical combination preparation comprising keto-profen
GB9516584D0 (en)	1995-10-11	Pharmaceutical formulations
GB9508989D0 (en)	1995-06-21	Pharmaceutical formulations
GB9503752D0 (en)	1995-04-12	Pharmaceutical formulations
HUP9602732A2 (en)	1997-09-29	Pharmaceutical composition comprising lanperisone
GB9414216D0 (en)	1994-08-31	Pharmaceutical formulations
GB9401738D0 (en)	1994-03-23	Pharmaceutical formulations
GB9408164D0 (en)	1994-06-15	Pharmaceutical formulations
GB9417953D0 (en)	1994-10-26	Pharmaceutical formulations